ArticleOncotarget2015

MYC or BCL2 copy number aberration is a strong predictor of outcome in patients with diffuse large B-cell lymphoma.

Ting-Xun Lu et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.